coli
-
ICON appoints Colin Stanley President of DOCS
Succeeds Bill Taaffe as President following his retirement earlier this year.
coli | 17 October 2011
-
Life Technologies develops test to detect Europe's deadly E coli
Life Technologies Corporation announced that it has developed a custom test (assay) to accurately detect the E coli bacterium that has killed at least 22 people and affected more than 2,100 worldwide, including four new cases reported in the United S…
coli | 07 June 2011
-
Richter-Helm BioLogics: Breakthrough in Purification of Antibody Fragments
Richter-Helm BioLogics has announced a technological breakthrough in the field of purification of antibody fragments from an E coli expression system. The company has finalized the downstream process for Phase III clinical trial material using Se…
coli | 08 June 2009
-
Danisco BioActives and Sigma-Tau Pharmaceuticals Announce Partnership Agreement
Danisco BioActives and Sigma-Tau Pharmaceuticals have signed a partnering agreement for the development of a biologic drug candidate which may help to prevent Necrotizing Enterocolitis (NEC). Under the terms of the agreement, the companies will co…
coli | 21 April 2009
-
New Colibrys VP global operations
Colibrys has appointed Don Stoops to the role of VP Global operations. He will be responsible worldwide for the strategic management of the Colibrys operations, hence including manufacturing, product development, quality, EH&S and central services. …
coli | 28 April 2008
-
NCI's Colin Steward Joins Singapore’s Institute of Medical Biology
Colin Stewart, from the National Cancer Institute (NCI) at Frederick, US, has joined the Institute of Medical Biology (IMB) under the Agency for Science, Technology and Research (A*STAR) as a Principal Investigator. Stewart, previously Chief of La…
coli | 11 December 2007
